3rd Quarter - Report

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$231,546
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

- The 340B Drug Discount program - Medicare Part B Drug Reimbursement, H.R. 2869 - Orphan Drug Rule, ACA implementation - SGR reform pay-fors

LobbyistCovered position, as disclosed
JOHN COSTER —
JEFFREY IRVING DAVIS —
KATHRYN DIBITETTO —
GREG DOGGETT —
TED SLAFSKY —
LIAM STEADMAN New —
MAUREEN TESTONI —

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE

Bills named: H.R. 2869 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.